Buprenorphine Coverage in the Medicare Part D Program for 2007 to 2018-Reference-Cited by-同舟云学术

Buprenorphine Coverage in the Medicare Part D Program for 2007 to 2018

Published:2019-02-12 Issue:6 Volume:321 Page:607
ISSN:0098-7484
Container-title:JAMA
language:en
Short-container-title:JAMA

Author:

Hartung Daniel M.¹,Johnston Kirbee¹,Geddes Jonah¹,Leichtling Gillian²,Priest Kelsey C.³,Korthuis P. Todd⁴

Affiliation:

1. College of Pharmacy, Oregon State University, Portland

2. HealthInsight Oregon, Portland

3. School of Public Health, Oregon Health & Science University, Portland

4. School of Medicine, Oregon Health & Science University, Portland

Publisher

American Medical Association (AMA)

Subject

General Medicine

Reference5 articles.

1. Use of opioid agonist therapy for Medicare patients in 2013.;Lembke;JAMA Psychiatry,2016

2. National Institute on Drug Abuse. Medications to treat opioid use disorder. https://www.drugabuse.gov/publications/research-reports/medications-to-treat-opioid-addiction/overview. Accessed October 30, 2018.

3. Centers for Medicare & Medicaid Services. Research, statistics, data and systems. https://www.cms.gov/Research-Statistics-Data-and-Systems/Research-Statistics-Data-and-Systems.html. Accessed October 30, 2018.

4. First Databank Inc. FDB MedKnowledge. https://www.fdbhealth.com/fdb-medknowledge/. Accessed October 30, 2018.

Cited by 27 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A feasibility study to assess the recruitment and retention of pregnant patients who regularly use cannabis;BMC Research Notes;2024-06-25

2. Unintended consequences of methadone regulation for opioid use disorder treatment among hospitalized patients;Journal of Hospital Medicine;2024-03-20

3. Racial/ethnic disparities in timely receipt of buprenorphine among Medicare disability beneficiaries;Drug and Alcohol Dependence;2023-11

4. Medicare Coverage of Buprenorphine-Naloxone Film Surrounding Generic Entry;The American Journal of Managed Care;2023-08-23

5. National Trends in Buprenorphine Treatment for Opioid Use Disorder From 2007 to 2018;Substance Abuse;2023-06-06